A major discovery in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in various kinds of tumors, leading uncontrolled https://todaybookmarks.com/story22108427/nanobodies-restore-the-p53-protein-the-promising-pathway-for-cancer-management